Purified recombinant SARS-CoV-2 P.3 Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 BA.2 (B.1.1.529.2) Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 BA.2.75 (B.1.1.529.2.75) Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 A.30 Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 BA.4/BA.5 (B.1.1.529.4/5) Spike protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 B.1.6172 receptor binding protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Purified recombinant SARS-CoV-2 receptor binding protein (trimerisation domain and C-terminal hexa histidine-tag) expressed in mammalian HEK293F cells as secreted protein
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.2/NV-22-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-007. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P7-GII.6/NV-22-008. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-009. Material 10-20% fecal material in virus culture medium.
